Evidence map›Paper›PMID 36942949›Full record

Observational studyEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients.

Martin Arnold, Mark Richards, Antonio D'Onofrio, Brett Faulknier, Michele Gulizia, Ranjan Thakur, Yasushi Sakata, Wenjiao Lin, Annalisa Pollastrelli, Andrea Grammatico and 2 more

Abstract readObservational Study
In one paragraph

Observational study in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Systematic review and meta-analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Dual-chamber vs. single-chamber pacemaker in patients in sinus rhythm with an atrioventricular block: a nationwide cohort study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Observational
  8. Article
  9. Cardiac pacing and lead devices management: 25 years of research at EP Europace journal.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Review
  10. Transient pacing pulse on the T-wave: What is the mechanism?Indian pacing and electrophysiology journal
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Martin ArnoldCardiology Department, Friedrich-Alexander-Universität, Erlangen, Germany.
Mark RichardsCardiology Department, Yakima Heart and Vascular, Yakima, WA, USA.ORCID 0000-0002-2197-6956
Antonio D'OnofrioCardiology Department, UOSD di Elettrofisiologia, Studio e Terapia delle Aritmie A.O.R.N. 'Ospedali dei Colli' Osp Monaldi, Napoli, Italy.ORCID 0000-0002-8739-5572
Brett FaulknierCardiology, West Virginia University, Vero Beach, FL, USA.
Michele GuliziaCardiology Department, Azienda Ospedaliera Garibaldi Nesima, Catania, Italy.ORCID 0000-0003-1513-7125
Ranjan ThakurCardiology Department, Thoracic Cardio Healthcare Foundation, Lansing, MI, USA.
Yasushi SakataCardiology Department, Osaka University Hospital, Osaka, Japan.ORCID 0000-0002-5618-4721
Wenjiao LinBiostatistics, Abbott, Sylmar, CA, USA.
Annalisa PollastrelliMedical Affairs, Abbott, Rome, Italy.
Andrea GrammaticoMedical Affairs, Abbott, Rome, Italy.ORCID 0000-0001-6204-8745
Angelo AuricchioClinical Electrophysiology Unit, Cardiocentro Ticino Institute, Lugano, Switzerland.ORCID 0000-0003-2116-6993
Giuseppe BorianiCardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena University Hospital, Via del Pozzo, 71, Modena 41124, Italy.ORCID 0000-0002-9820-4815

Funding

Abbott. St. Jude Medical
6 · The paper itself

Abstract

aimsIn bradycardia patients treated with dual-chamber pacing, we aimed to evaluate whether pacing with atrioventricular (AV) delay management [AV hysteresis (AVH)], compared with standard pacing with fixed AV delays, reduces unnecessary ventricular pacing percentage (VPP) and is associated with better clinical outcomes. Main study endpoints were the incidence of heart failure hospitalizations (HFH), persistent atrial fibrillation (AF), and cardiac death. METHODS AND

resultsData from two identical prospective observational studies, BRADYCARE I in the USA and BRADYCARE II in Europe, Africa, and Asia, were pooled. Overall, 2592 patients (75 ± 10 years, 45.1% female, 50% with AVH) had complete clinical and device data at 1-year follow-up and were analysed. Primary pacing indication was sinus node disease (SND) in 1177 (45.4%), AV block (AVB) in 974 (37.6%), and other indications in 441 (17.0%) patients. Pacing with AVH, compared with standard pacing, was associated with a lower 1-year incidence of HFH [1.3% vs. 3.1%, relative risk reduction (RRR) 57.5%, P = 0.002] and of persistent AF (5.3% vs. 7.7%, RRR = 31.1%, P = 0.028). Cardiac mortality was not different between groups (1.0% vs. 1.4%, RRR = 27.8%, P = 0.366). Pacing with AVH, compared with standard pacing, was associated with a lower (P < 0.001) median VPP in all patients (7% vs. 75%), in SND (3% vs. 44%), in AVB (25% vs. 98%), and in patients with other pacing indications (3% vs. 47%).

conclusionCardiac pacing with AV delay management via AVH is associated with reduced 1-year incidence of HFH and persistent AF, most likely due to a reduction in VPP compared to standard pacing.

Indexed as

Atrial FibrillationHeart FailurePacemaker, ArtificialCardiac Pacing, ArtificialFemaleHospitalizationHumansIncidenceMaleSick Sinus SyndromeTreatment OutcomeAV blockAV hysteresisHeart failurePacemakerSinus node dysfunctionVentricular pacing

Identifiers

PMID36942949
PMCPMC10227662

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.